Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Identify which bonds minimize taxes in retirement and why they work. This quick guide outlines tax-smart bond choices for retirees.
21,839 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Ethereum's staking boom pushes 36 million ETH into validators, locking up a large share of supply and easing exit pre...
Citi upgraded AMD to Buy with a $575 price target, sending shares higher and reigniting the AI GPU narrative. Investo...
Investors are quietly shifting capital away from high-velocity AI bets and toward steady cash-flow leaders. Discover ...
Ripple's XRPL launches an AI Starter Kit to enable autonomous AI agents to transact with XRP and RLUSD, aiming to lea...
Reve 2.0 promises layout-first AI imagery at 4K. This reve review: best image examines how it works, who benefits, an...
The dramatic shift policy just signaled by the Fed has set the stage for a new era in healthcare investing. Bristol M...
A once unimaginable moment is explored: spacex surpassed broadcom, meta on IPO day. This piece breaks down what that ...
Two aviation ETFs pull in opposite directions: JETS targets airlines and airports, ITA leans into defense and aerospa...
Goldman Sachs names Marvell Technology and Micron Technology as the linchpins of the next AI deployment cycle, elevat...
As Rocket Lab broadens beyond launches into aerospace and defense, a renewed thesis supports a potential growth path ...
Stocks wobble as a fresh batch of analyst notes lands on top names like Albemarle, American Express and CME Group. He...